Evidence map›Paper›PMID 33242142›Full record

SynthesisArchives of gynecology and obstetrics2021

Comparing prophylactic use of cefazolin for SSI in cesarean section: a systematic review and meta-analysis.

Meilin Li, Bingzhi Shi, Junru Ma, Xinyue Peng, Jiemin Shi

Abstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Archives of gynecology and obstetrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. A Predictive Nomogram for Post-Cesarean Infections: Risk Factors and Clinical Implications.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Meilin LiThe First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China.ORCID 0000-0002-3675-5523
Bingzhi ShiThe First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China.
Junru MaThe First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China. majunru@sina.com.ORCID 0000-0002-2180-3828
Xinyue PengThe First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China.
Jiemin ShiThe First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China.
First Affiliated Hospital of Chengdu Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo summarize the available evidence to explore the effect of different prophylactic cefazolin regimens on postoperative surgical site infection after cesarean section.

methodsWe searched WOS, Pubmed, and EMBASE Database also traced citations in the reference sections of the retrieved studies. English search words: Cesarean section, Surgical site infection, Cefazolin. The majority of the literature are randomized controlled trials comparing varied regimens of cefazolin.

resultsA total of 11 randomized controlled trials and 4 non-randomized controlled trials involving 16,328 pregnant women were eligible. There was no statistically significant difference in the risk of SSI after cesarean section when cefazolin was given at a high dose compared with cefazolin at a low dose (OR 0.77, 95% CI 0.57-1.04, I

conclusionsAll in all, this article illustrates a better use of cefazolin for the control of Surgical incision site infection in the cesarean section. For pregnant women with cesarean section without high-risk factors of infection, the use of cefazolin is effective, but for pregnant women with different high-risk factors, the specific use of prophylactic antibiotics needs to be further explored.

Indexed as

Anti-Bacterial AgentsAntibiotic ProphylaxisBacterial InfectionsCefazolinCesarean SectionDose-Response Relationship, DrugFemaleHumansPostoperative ComplicationsPregnancyRisk FactorsSurgical Wound InfectionAnti-Bacterial AgentsCefazolinCefazolinCesarean sectionSurgical site infection

Identifiers

PMID33242142
OpenAlexW3108968864

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.